Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Palliative care service demand could rise amid the pandemic.
“The demand for palliative care services (at home or residential care facilities, in hospitals or hospices) may increase and this should be adapted to respond rapidly and flexibly during the pandemic [97], within the scope of availability of staff and other health-care resources.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 2 · Cited by 32
Research works printed but not linked: 1
- [3]Curigliano G The treatment of patients with cancer and containment of COVID-19: experiences from Italy https://dailynews.ascopubs.org/do/10.1200/ADN.20.200068/full/ March 17, 2020 · DOI
- Authors
- de Paula, B. H. R., Araújo, I., Bandeira, L., Barreto, N. M. P. B., & Doherty, G. J.
- Affiliations
- University of Vassouras (BR)
- Hospital Pró-Cardíaco (BR)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 21
- Issue
- 5
- Pages
- 624-627
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC7252196
- OpenAlex
- W3015151141
- Cited by
- 32
- References
- 2
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 2 · 2021: 9 · 2020: 18 · 2019: 1
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Birmingham
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Social Sciences › Education › Education during COVID-19 pandemic
- Keywords
- COVID-19 pandemic, cancer clinical trials, national regulatory agencies, clinical trial recruitment, oncology clinic, personalised cancer therapy
- MeSH terms
- COVID-19, Clinical Trials as Topic, Colombia, Government Agencies, United Kingdom, Humans, Neoplasms, Norway, Pneumonia, Viral, United States, United States Food and Drug Administration, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
